Response to Comments: MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer

This document is a response-to-comments notice for the MolDX Local Coverage Determination DL38586 concerning prognostic and predictive molecular classifiers for bladder cancer. It records the comment period (05/28/2020–07/12/2020), notice start (06/03/2021), and LCD effective date (07/18/2021) but does not itself provide specific coverage, limitation, or frequency criteria — consult DL38586 for coverage rules.

"This document is a response to comments regarding MolDX LCD DL38586 (Prognostic and Predictive Molecular Classifiers for Bladder Cancer) and does not itself state coverage criteria."

Sign up to see full coverage criteria, indications, and limitations.